A carregar...
Personalized radioiodine therapy for thyroid cancer patients with known disease
Radioactive iodine (RAI) (131)I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to (131)I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients’ lesions. A pers...
Na minha lista:
| Publicado no: | Fac Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Faculty Opinions Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8103907/ https://ncbi.nlm.nih.gov/pubmed/33977289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/r/10-36 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|